Fig. 3.
Fig. 3. Survival and overall duration of immunosuppressive treatment. / Survival and overall duration of immunosuppressive treatment were similar for patients with chronic GVHD after PBSCT and after BMT. Upper curves indicate the probability of relapse-free survival after the diagnosis of chronic GVHD (P = .08). Lower curves indicate the probability of discontinuing all immunosuppressive (D/C IS) treatment after the diagnosis of chronic GVHD (P = .08). The space between the upper and lower curves indicates patients who are alive with continued immunosuppressive therapy. Follow-up was censored at the time of recurrent malignancy.

Survival and overall duration of immunosuppressive treatment.

Survival and overall duration of immunosuppressive treatment were similar for patients with chronic GVHD after PBSCT and after BMT. Upper curves indicate the probability of relapse-free survival after the diagnosis of chronic GVHD (P = .08). Lower curves indicate the probability of discontinuing all immunosuppressive (D/C IS) treatment after the diagnosis of chronic GVHD (P = .08). The space between the upper and lower curves indicates patients who are alive with continued immunosuppressive therapy. Follow-up was censored at the time of recurrent malignancy.

Close Modal

or Create an Account

Close Modal
Close Modal